Cancer Immunotherapies: Assessing the Value

from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2GkhyR5 on February 17, 2018 at 07:30PM A recent feature in Value and Outcomes Spotlight, a publication by the International Society for Pharmacoeconomics and Outcomes Research, delves into how the health industry is undertaking value assessments for cancer immunotherapies. Christiane Truelove in her write up discusses how European […]

ICER Reports to Assess Amyloidosis, Prostate Cancer Treatments

from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2o75Rqj on February 17, 2018 at 06:30PM The Institute for Clinical and Economic Review (ICER) says upcoming reports will focus on the comparative clinical effectiveness and value of high-risk prostate cancer and hereditary amyloidosis treatments. According to a press release, the reports will be reviewed during the September […]